This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Recent Price Trend in Standex (SXI) is Your Friend, Here's Why
by Zacks Equity Research
Standex (SXI) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
FLS vs. SXI: Which Stock Is the Better Value Option?
by Zacks Equity Research
FLS vs. SXI: Which Stock Is the Better Value Option?
Standex (SXI) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Standex (SXI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here's Why Momentum in Standex (SXI) Should Keep going
by Zacks Equity Research
Standex (SXI) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here's What Could Help Standex (SXI) Maintain Its Recent Price Strength
by Zacks Equity Research
Standex (SXI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Standex International (SXI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 5.10% and 3.19%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ingersoll Rand (IR) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ingersoll (IR) delivered earnings and revenue surprises of 25% and 10.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Idex (IEX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 2.96% and 3.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Standex International (SXI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 2.35% and 1.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Graco Inc. (GGG) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Graco Inc. (GGG) delivered earnings and revenue surprises of 7.35% and 1.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Applied Industrial Technologies, Standex International, Hubbell and Twin Disc
by Zacks Equity Research
Applied Industrial Technologies, Standex International, Hubbell and Twin Disc are included in this Analyst Blog.
4 Solid Stocks to Buy on Rise in September Factory Orders
by Ritujay Ghosh
Continued demand for goods is driving orders at U.S. factories, helping stocks like Applied Industrial Technologies (AIT), Standex International (SXI), Hubbell (HUBB) and Twin Disc (TWIN).
Standex International (SXI) Q1 Earnings Match Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 0% and 3.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here is Why Growth Investors Should Buy Standex (SXI) Now
by Zacks Equity Research
Standex (SXI) possesses solid growth attributes, which could help it handily outperform the market.
The Zacks Analyst Blog Highlights Hubbell, Graham, Twin Disc and Standex International Corporation
by Zacks Equity Research
Hubbell, Graham, Twin Disc and Standex International Corporation are included in this Analyst Blog.
4 Stocks to Buy on Continued Growth in Industrial Production
by Ritujay Ghosh
Industrial production has been on the rise amid several challenges, helping stocks like Hubbell (HUBB), Graham Corporation (GHM), Twin Disc (TWIN) and Standex International (SXI).
Is Standex (SXI) a Suitable Value Investor Stock Now?
by Zacks Equity Research
Let's see if Standex (SXI) stock is a good choice for value-oriented investors right now from multiple angles.
Standex International (SXI) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 4.76% and 1.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
EnPro Industries (NPO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
EnPro (NPO) delivered earnings and revenue surprises of 28.18% and 1.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SXI vs. FLS: Which Stock Is the Better Value Option?
by Zacks Equity Research
SXI vs. FLS: Which Stock Is the Better Value Option?
SXI vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SXI vs. IEX: Which Stock Is the Better Value Option?
Standex International (SXI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 3.36% and 1.93%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Flowserve (FLS) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Flowserve (FLS) delivered earnings and revenue surprises of -66.67% and 4.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investing in Zebra (ZBRA) Stock Now Makes Sense
by Zacks Equity Research
Zebra (ZBRA) is poised to benefit from robust product demand, acquired assets, healthy cash flows and shareholder-friendly policies.
Illinois Tool (ITW) Exhibits Strong Prospects Despite Risks
by Zacks Equity Research
Illinois Tool (ITW) is poised to benefit from its diverse end-market exposure, acquired assets and shareholder-friendly policies. However, high debt levels remain concerning.